| 1 |
33538958 | Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. | 2021 Feb 4 |
1 |
| 2 |
33985511 | Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy. | 2021 May 13 |
4 |
| 3 |
34211587 | External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry. | 2021 |
1 |
| 4 |
34268956 | Efficacy of trastuzumab combined with SOX or IP chemotherapy regimen in the treatment of advanced gastric cancer. | 2021 May-Jun |
2 |
| 5 |
34386088 | Anthelminthic niclosamide inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor 2-positive breast cancer. | 2021 Sep |
4 |
| 6 |
34729945 | HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer. | 2021 Dec |
6 |
| 7 |
35070983 | Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation. | 2021 |
1 |
| 8 |
31790894 | Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. | 2020 Jan |
1 |
| 9 |
32117718 | Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway. | 2020 |
1 |
| 10 |
32269724 | Exploring cisplatin resistance in ovarian cancer through integrated bioinformatics approach and overcoming chemoresistance with sanguinarine. | 2020 |
1 |
| 11 |
32494981 | Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials. | 2020 Sep |
1 |
| 12 |
32943881 | Pathological Complete Response from Pyrotinib Combined with Trastuzumab, Paclitaxel and Cisplatin in a Postpartum Woman with HER2-Positive Locally Advanced Breast Cancer: A Case Report. | 2020 |
1 |
| 13 |
33042632 | Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study. | 2020 |
2 |
| 14 |
30088161 | Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer. | 2019 Mar |
1 |
| 15 |
30711995 | Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202. | 2019 Feb |
3 |
| 16 |
30799422 | A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of Cisplatin. | 2019 |
2 |
| 17 |
30809308 | Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles. | 2019 |
1 |
| 18 |
30856589 | Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy. | 2019 Jun 1 |
2 |
| 19 |
30927036 | Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial. | 2019 Jun |
1 |
| 20 |
31102009 | Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer. | 2019 Nov |
1 |
| 21 |
31521263 | Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer. | 2019 Dec 1 |
1 |
| 22 |
31772741 | Treatment of HER2+ metastatic salivary ductal carcinoma in a pregnant woman: a case report. | 2019 Oct |
1 |
| 23 |
32156946 | [Two Cases of Complete Response to Trastuzumab Combined with Chemotherapy for Recurrence of HER2-Positive Gastric Cancer]. | 2019 Dec |
1 |
| 24 |
26780095 | Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine. | 2018 |
2 |
| 25 |
28343375 | FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation. | 2018 Jan |
1 |
| 26 |
29090377 | Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study. | 2018 Feb |
1 |
| 27 |
29174919 | Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. | 2018 Apr |
1 |
| 28 |
29290024 | A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study). | 2018 Feb |
2 |
| 29 |
29434871 | Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways. | 2018 Feb |
2 |
| 30 |
29451302 | Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysis. | 2018 Jul 15 |
2 |
| 31 |
30145203 | Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target. | 2018 Nov 28 |
1 |
| 32 |
30692485 | [A Case of Hepatic Resection after Neoadjuvant Chemotherapy for Single Liver Metastasis from Gastric Cancer with Positive Human Epidermal Growth Factor Receptor 2]. | 2018 Dec |
2 |
| 33 |
28160563 | Tumor suppressor role of miR-3622b-5p in ERBB2-positive cancer. | 2017 Apr 4 |
1 |
| 34 |
28234911 | Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer. | 2017 |
1 |
| 35 |
28260018 | Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line. | 2017 Apr |
1 |
| 36 |
28526406 | Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models. | 2017 Jul 8 |
1 |
| 37 |
28850174 | Chemotherapy for advanced gastric cancer. | 2017 Aug 29 |
2 |
| 38 |
28913549 | Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107. | 2017 Nov |
3 |
| 39 |
29108309 | Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study. | 2017 Oct 3 |
1 |
| 40 |
26846307 | Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. | 2016 Feb 5 |
5 |
| 41 |
26893657 | Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2. | 2016 Feb |
1 |
| 42 |
27002325 | A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer. | 2016 May |
2 |
| 43 |
27284358 | HER2-positive gastric cancer identified by serum HER2: A case report. | 2016 Jun |
1 |
| 44 |
27760940 | [A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy]. | 2016 Oct |
2 |
| 45 |
25143433 | Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms. | 2015 Jan |
1 |
| 46 |
25624920 | Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins. | 2015 Feb |
2 |
| 47 |
25661103 | Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer. | 2015 Mar |
1 |
| 48 |
25744576 | Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study. | 2015 Apr |
1 |
| 49 |
25812508 | [A case of HER2-positive advanced gastric cancer successfully treated via capecitabine, cisplatin, and trastuzumab combination chemotherapy]. | 2015 Mar |
3 |
| 50 |
26047983 | Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer. | 2015 Oct |
1 |